NCT05614778View on ClinicalTrials.gov

Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis

CompletedOBSERVATIONAL
Enrollment

2,881

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

February 1, 2024

Study Completion Date

May 31, 2024

Conditions
Osteoporosis
Interventions
OTHER

Zoledronic Acid injection, 5mg/100mL

Zoledronic Acid injection, 5mg/100mL

Trial Locations (1)

Unknown

Yonsei Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY